These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22366402)

  • 1. Spinal cord clinical trials and the role for bioengineering.
    Wilcox JT; Cadotte D; Fehlings MG
    Neurosci Lett; 2012 Jun; 519(2):93-102. PubMed ID: 22366402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineered strategies for spinal cord repair.
    Nomura H; Tator CH; Shoichet MS
    J Neurotrauma; 2006; 23(3-4):496-507. PubMed ID: 16629632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions for spinal cord injury: where do we stand? How might we step forward?
    Rabchevsky AG; Patel SP; Springer JE
    Pharmacol Ther; 2011 Oct; 132(1):15-29. PubMed ID: 21605594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From basics to clinical: a comprehensive review on spinal cord injury.
    Silva NA; Sousa N; Reis RL; Salgado AJ
    Prog Neurobiol; 2014 Mar; 114():25-57. PubMed ID: 24269804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury.
    Hawryluk GW; Rowland J; Kwon BK; Fehlings MG
    Neurosurg Focus; 2008; 25(5):E14. PubMed ID: 18980474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regenerative Therapies for Spinal Cord Injury.
    Ashammakhi N; Kim HJ; Ehsanipour A; Bierman RD; Kaarela O; Xue C; Khademhosseini A; Seidlits SK
    Tissue Eng Part B Rev; 2019 Dec; 25(6):471-491. PubMed ID: 31452463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages.
    Gensel JC; Donnelly DJ; Popovich PG
    Expert Opin Ther Targets; 2011 Apr; 15(4):505-18. PubMed ID: 21281256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the treatment of spinal cord injury.
    Baptiste DC; Fehlings MG
    Prog Brain Res; 2007; 161():217-33. PubMed ID: 17618980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell therapy in spinal cord injuries: current concepts.
    Chhabra HS
    J Assoc Physicians India; 2012 May; 60 Suppl():30-3. PubMed ID: 23155794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to restore motor functions after spinal cord injury.
    Boulenguez P; Vinay L
    Curr Opin Neurobiol; 2009 Dec; 19(6):587-600. PubMed ID: 19896827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord injury clinical trials translational process, review of past and proposed acute trials with reference to recommended trial guidelines.
    Steeves J; Blight A
    Handb Clin Neurol; 2012; 109():386-98. PubMed ID: 23098726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.
    Ahuja CS; Fehlings M
    Stem Cells Transl Med; 2016 Jul; 5(7):914-24. PubMed ID: 27130222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury.
    Tator CH; Hashimoto R; Raich A; Norvell D; Fehlings MG; Harrop JS; Guest J; Aarabi B; Grossman RG
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):157-229. PubMed ID: 22985382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic interventions after spinal cord injury.
    Thuret S; Moon LD; Gage FH
    Nat Rev Neurosci; 2006 Aug; 7(8):628-43. PubMed ID: 16858391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-based transplantation strategies to promote plasticity following spinal cord injury.
    Ruff CA; Wilcox JT; Fehlings MG
    Exp Neurol; 2012 May; 235(1):78-90. PubMed ID: 21333647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational research in spinal cord injury: a survey of opinion from the SCI community.
    Kwon BK; Hillyer J; Tetzlaff W
    J Neurotrauma; 2010 Jan; 27(1):21-33. PubMed ID: 19751098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection in spinal cord injury.
    Wyndaele JJ
    Spinal Cord; 2009 Oct; 47(10):715. PubMed ID: 19794416
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical relevance of gait research applied to clinical trials in spinal cord injury.
    Ditunno J; Scivoletto G
    Brain Res Bull; 2009 Jan; 78(1):35-42. PubMed ID: 18848865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opinions on the preclinical evaluation of novel therapies for spinal cord injury: a comparison between researchers and spinal cord-injured individuals.
    Kwon BK; Ghag A; Reichl L; Dvorak MF; Illes J; Tetzlaff W
    J Neurotrauma; 2012 Sep; 29(14):2367-74. PubMed ID: 22776047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection: challenges and opportunities.
    Faden AI; Stoica B
    Arch Neurol; 2007 Jun; 64(6):794-800. PubMed ID: 17562927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.